Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Callewaert · SciRah

Researcher profile · Semantic Scholar

K. Callewaert

Share profile

K. Callewaert — researcher profile on SciRah

h-index: 11
Works: 19
Citations: 1,566

Most-cited papers

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.
E. Lawitz, M. Sulkowski, R. Ghalib, M. Rodríguez-Torres +18 more
2014The Lancet845 citations
Semantic Scholar
Evaluation of a Mosaic HIV-1 Vaccine in a Randomized, Double-Blinded, Placebo-Controlled Phase I/IIa Clinical Trial and in Rhesus Monkeys
D. Barouch, F. Tomaka, F. Wegmann, D. Stieh +52 more
2018The Lancet290 citations Open access
Semantic Scholar
svr results of a once-daily regimen of simeprevir (tmc435) plus sofosbuvir (gs-7977) with or without ribavirin in cirrhotic and non-cirrhotic Hcv genotype 1 treatment-naïve and prior null responder patients: The Cosmos study : lb-3
I. Jacobson, R. Ghalib, M. Rodríguez-Torres, Z. Younossi +17 more
2013120 citations
Semantic Scholar
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
L. Baden, D. Stieh, M. Sarnecki, S. Walsh +37 more
2020The Lancet HIV65 citations Open access
Semantic Scholar
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
L. Baden, S. Walsh, Michael S. Seaman, Yehuda Z. Cohen +71 more
2018Journal of Infectious Diseases41 citations Open access
Semantic Scholar
O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)
E. Lawitz, R. Ghalib, M. Rodríguez-Torres, Z. Younossi +17 more
201438 citations
Semantic Scholar
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study
D. Stieh, D. Barouch, C. Comeaux, M. Sarnecki +24 more
2022Journal of Infectious Diseases37 citations Open access
Semantic Scholar
O7 ONCE-DAILY SIMEPREVIR (TMC435) PLUS SOFOSBUVIR (GS-7977) WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL RESPONDERS WITH METAVIR F0–2: COSMOS STUDY SUBGROUP ANALYSIS
M. Sulkowski, Ira M. Jacobson, R. Ghalib, M. Rodríguez-Torres +10 more
201436 citations
Semantic Scholar
Determination of cotinine in biological fluids by capillary gas chromatography-mass spectrometry-selected-ion monitoring.
P. Daenens, L. Laruelle, K. Callewaert, P. de Schepper +2 more
1985Journal of Chromatography A36 citations
Semantic Scholar
Sa2073 SVR4 Results of a Once Daily Regimen of Simeprevir (TMC435) Plus Sofosbuvir (GS-7977) With or Without Ribavirin (RBV) in HCV GT 1 Null Responders
E. Lawitz, R. Ghalib, M. Rodríguez-Torres, Z. Younossi +6 more
201327 citations Open access
Semantic Scholar
Absolute quantitation of binding antibodies from clinical samples
Chan Tang, A. Verwilligen, Jerald Sadoff, Boerries Brandenburg +14 more
2024npj Vaccines14 citations Open access
Semantic Scholar
Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH
J. van Duijn, D. Stieh, N. Fernandez, Deborah King +9 more
2023Journal of Virology10 citations Open access
Semantic Scholar
The IL-6 Hypothesis in COVID-19: A Phase 2, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Free IL-6 Sequestration by the Monoclonal Antibody Sirukumab in Severe and Critical COVID-19.
Robert L. Gottlieb, Meredith E. Clement, P. Cook, Audra Deveikis +14 more
2024Journal of Infection5 citations Open access
Semantic Scholar
Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial
Jing Gao, Zhong-Feng Huang, F. Ren, Yu-Qing Wu +21 more
2026Infection2 citations Open access
Semantic Scholar
Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab
K. Thys, M. Loza, Linghua Lynn, K. Callewaert +7 more
2024Scientific Reports1 citations Open access
Semantic Scholar
Vaccine-induced seropositivity/seroreactivity (VISP/R) on common HIV screening assays after vaccination with investigational adenovirus vector-based mosaic HIV regimens in clinical trials.
K. Callewaert, L. Lavreys, Wouter Willems, Mariska G. M. van Rosmalen +5 more
2026Vaccine0 citations Open access
Semantic Scholar
B14-10 Randomized Phase 2/3 Trial of an All-Oral Bedaquiline-Based Regimen for Refractory Mycobacterium Avium Complex (MAC) Lung Disease
K. Morimoto, N. Hasegawa, S. Mitarai, M. Kawai +10 more
2026American Journal of Respiratory and Critical Care Medicine0 citations
Semantic Scholar
QT prolongation in participants receiving bedaquiline-containing regimens: analysis of data from Phase 3 STREAM Stage 2
E. Birmingham, B. Remmerie, I. Leipoldt, I. Eshun-Wilsonova +2 more
2026IJTLD open0 citations Open access
Semantic Scholar
LB-1 Phase 2b study of the interferon-free and ribavirin-free combination of daclatasvir, asunaprevir, and BMS-791325 for 12 weeks in treatment-naïve patients with chronic HCV genotype 1 infection
I. Jacobson, R. Ghalib, M. Rodríguez-Torres, Z. Younossi +21 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Lawitz×6
Invite
E. Lawitz — researcher profile on SciRah
R. Ghalib×6
Invite
R. Ghalib — researcher profile on SciRah
M. Rodríguez-Torres×6
Invite
M. Rodríguez-Torres — researcher profile on SciRah
Z. Younossi×6
Invite
Z. Younossi — researcher profile on SciRah

×6

Invite

A. Corregidor — researcher profile on SciRah

Invite

W. Symonds — researcher profile on SciRah

Invite

G. Picchio — researcher profile on SciRah

Invite

M. Pau — researcher profile on SciRah

M. Sulkowski×5

Invite

M. Sulkowski — researcher profile on SciRah

Invite

B. Fevery — researcher profile on SciRah

S. Ouwerkerk-Mahadevan×5

Invite

S. Ouwerkerk-Mahadevan — researcher profile on SciRah

Invite

K. Lindsay — researcher profile on SciRah